The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACTAVIS PLC | SHS | G0083B108 | 2,976 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
| AEGERION PHARMACEUTICALS INC | COM | 00767E102 | 654 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
| ALBANY MOLECULAR RESH INC | COM | 012423109 | 2,112 | 120,000 | SH | Call | SOLE | 120,000 | 0 | 0 | |
| ALBANY MOLECULAR RESH INC | COM | 012423109 | 9,546 | 542,400 | SH | SOLE | 542,400 | 0 | 0 | ||
| ALIMERA SCIENCES INC | COM | 016259103 | 251 | 50,000 | SH | Call | SOLE | 50,000 | 0 | 0 | |
| ALIMERA SCIENCES INC | COM | 016259103 | 501 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| ALLIQUA BIOMEDICAL INC | COM NEW | 019621200 | 1,019 | 196,000 | SH | SOLE | 196,000 | 0 | 0 | ||
| AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 468 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 468 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | |
| APRICUS BIOSCIENCES INC | COM | 03832V109 | 935 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| ARIAD PHARMACEUTICALS INC | COM | 04033A100 | 824 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
| ARIAD PHARMACEUTICALS INC | COM | 04033A100 | 1,236 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| ASTRAZENECA PLC | SPONSORED ADR | 046353108 | 6,843 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| ASTRAZENECA PLC | SPONSORED ADR | 046353108 | 10,265 | 150,000 | SH | Call | SOLE | 150,000 | 0 | 0 | |
| CELSION CORPORATION | COM PAR $0.01 | 15117N404 | 214 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
| CRYOLIFE INC | COM | 228903100 | 2,292 | 221,000 | SH | SOLE | 221,000 | 0 | 0 | ||
| CYTOKINETICS INC | COM NEW | 23282W605 | 678 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| FIBROCELL SCIENCE INC | COM NEW | 315721209 | 712 | 157,769 | SH | SOLE | 157,769 | 0 | 0 | ||
| LIGAND PHARMACEUTICALS INC | COM NEW | 53220K504 | 3,856 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| MANNKIND CORP | COM | 56400P201 | 2,600 | 500,000 | SH | Put | SOLE | 500,000 | 0 | 0 | |
| PFIZER INC | COM | 717081103 | 5,219 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| PROSHARES TR | ULTSH NASD BIOT | 74347B789 | 863 | 25,000 | SH | Call | SOLE | 25,000 | 0 | 0 | |
| PROSHARES TR | ULTSH NASD BIOT | 74347B789 | 3,450 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| PROSHARES TR | ULTSHT RUSS2000 | 74348A319 | 7,120 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| QLT INC | COM | 746927102 | 587 | 150,000 | SH | Call | SOLE | 150,000 | 0 | 0 | |
| QLT INC | COM | 746927102 | 3,567 | 912,200 | SH | SOLE | 912,200 | 0 | 0 | ||
| QUEST DIAGNOSTICS INC | COM | 74834L100 | 5,933 | 77,208 | SH | SOLE | 77,208 | 0 | 0 | ||
| RIGEL PHARMACEUTICALS INC | COM NEW | 766559603 | 536 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| SANOFI | SPONSORED ADR | 80105N105 | 3,214 | 65,000 | SH | Call | SOLE | 65,000 | 0 | 0 | |
| SORRENTO THERAPEUTICS INC | COM NEW | 83587F202 | 1,445 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
| STEMLINE THERAPEUTICS INC | COM | 85858C107 | 362 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
| SUNESIS PHARMACEUTICALS INC | COM NEW | 867328601 | 490 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| SUNESIS PHARMACEUTICALS INC | COM NEW | 867328601 | 490 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | |
| TEVA PHARMACEUTICAL INDS LTD | ADR | 881624209 | 3,115 | 50,000 | SH | Call | SOLE | 50,000 | 0 | 0 | |
| TEVA PHARMACEUTICAL INDS LTD | ADR | 881624209 | 6,230 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| ZOGENIX INC | COM | 98978L105 | 685 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||